Soare et al. found that DPP4 acts as a marker of fibroblast activation in systemic sclerosis [14]; Nonetheless, the role of DPP4 in pulmonary fibrosis and the potential therapeutic effects of DPP4 inhibitors in this context have not been studied. The gene discussed is DPP4; the disease is systemic sclerosis.